Hideto Oshikawa

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study.

Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study.

Journal: Modern rheumatology

Published: August 14, 2025

Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).

Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).

Journal: Modern rheumatology

Published: February 29, 2024

Dermatomyositis-related interstitial lung disease mimicking COVID-19 pneumonia.

Dermatomyositis-related interstitial lung disease mimicking COVID-19 pneumonia.

Journal: Cleveland Clinic journal of medicine

Published: September 02, 2021

Generalised edema with human parvovirus B19 infection.

Generalised edema with human parvovirus B19 infection.

Journal: BMJ case reports

Published: July 13, 2021

Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study).

Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study).

Journal: Modern rheumatology

Published: May 30, 2021

Risk of serious infection, malignancy, or death in Japanese rheumatoid arthritis patients treated with a combination of abatacept and tacrolimus: a retrospective cohort study.

Risk of serious infection, malignancy, or death in Japanese rheumatoid arthritis patients treated with a combination of abatacept and tacrolimus: a retrospective cohort study.

Journal: Clinical rheumatology

Published: September 30, 2020

Brainstem Posterior Reversible Encephalopathy Syndrome.

Brainstem Posterior Reversible Encephalopathy Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: June 11, 2019

Evaluation of the effect of foot disease activity on Boolean remission in Japanese patients with rheumatoid arthritis: A cross-sectional study.

Evaluation of the effect of foot disease activity on Boolean remission in Japanese patients with rheumatoid arthritis: A cross-sectional study.

Journal: Musculoskeletal care

Published: September 07, 2018

Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet's syndrome for patients in the US and Japan: data from a large, three-center cohort study.

Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet's syndrome for patients in the US and Japan: data from a large, three-center cohort study.

Journal: Modern rheumatology

Published: January 11, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026